LND topic: egfr page 1

egfr

A New Weapon in the Battle Against Lung Cancer

November 10, 2025

Lung cancer is a major health issue around the world. Among the different types, non-small cell lung cancer (NSCLC) is particularly tough to treat. However, a new drug named osimertinib is making waves. It's not your typical cancer treatment. Instead, it's designed to target specific EGFR gene mutat

health

Breaking Barriers: A New Hope for Lung Cancer Treatment

November 2, 2025

Lung cancer is a tough opponent, especially when it's the non-small-cell kind (NSCLC). Doctors usually don't recommend a common treatment called EGFR-TKIs for a specific mutation called EGFR exon 20 insertion. Why? Because these mutations don't respond well to the treatment. But here's a twist: a sp

health

Unlocking the Secrets of Nasopharyngeal Carcinoma Treatment

November 2, 2025

Nasopharyngeal carcinoma (NPC) is a big problem in Southeast Asia and southern China. Many people get it, but it's often found too late. Doctors have been using drugs that target a protein called EGFR to fight it. These drugs work at first, but the cancer cells find ways to resist them. Scientists

health

A New Hope for Brain Metastasis in Lung Cancer

October 24, 2025

Lung cancer is a tough opponent, especially when it spreads to the brain. The blood-brain barrier, a protective shield, often stops treatments from reaching brain tumors. Osimertinib, a drug used to treat a specific type of lung cancer, can cross this barrier. However, some cancer cells develop resi

health

How Two Proteins Affect Lung Cancer and Treatment

May 18, 2025

Lung cancer is a major health issue, with non-small cell lung cancer (NSCLC) making up most cases. This type of cancer often involves a gene called EGFR, which can be targeted with special drugs. However, these drugs often stop working over time. This is where things get interesting. Scientists have

science

The Many Faces of EGFR: How Ligands Shape Its Dance

December 29, 2024

Imagine a tiny protein named EGFR as a dancer in a ballet. It has partners, called ligands, that change its moves. Scientists recently explored seven of these partners and found something amazing. Each ligand makes EGFR move differently, like a dancer to different music. This might change how well E

health

The Impact of Osimertinib on Post-Surgery and Initial Advanced NSCLC

November 28, 2024

Osimertinib has been a game-changer in treating advanced non-small-cell lung cancer (NSCLC). But how does it fare when used as a first-line treatment for patients who have had surgery and later experienced a recurrence? That's a question that needs answering. While we know that post-surgery recurren